Treatment for Adolescents with Depression Study (TADS): safety results
about
Interventions for self-harm in children and adolescentsNewer generation antidepressants for depressive disorders in children and adolescentsPredictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) studyExcessive mood elevation and behavioral activation with antidepressant treatment of juvenile depressive and anxiety disorders: a systematic reviewAnxiety in adolescents: Update on its diagnosis and treatment for primary care providersAssessment of safety and long-term outcomes of initial treatment with placebo in TADS.Suicidality in pediatric bipolar disorder.Pediatric depression: is there evidence to improve evidence-based treatments?Drug-metabolizing enzyme genotypes and aggressive behavior treatment response in hospitalized pediatric psychiatric patients.The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step.Antidepressant-coincident mania in children and adolescents treated with selective serotonin reuptake inhibitors.Practitioner review: Self-harm in adolescents.Frequency and correlates of suicidal ideation in pediatric obsessive-compulsive disorderThe addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial.Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomesRelationship of dropout and psychopathology in a high school sample in Mexico.Correlates of Nonsuicidal Self-Injury and Suicide Attempts Among Tertiary Care, Emergency Department Patients.Predicting Anxiety Diagnoses and Severity with the CBCL-A: Improvement Relative to Other CBCL Scales?Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.What's the harm in asking about suicidal ideation?Sleep-Related Problems and the Effects of Anxiety Treatment in Children and Adolescents.Psychotropic medication treatment of adolescents: results from the National Comorbidity Survey-Adolescent Supplement.Evidence-based psychosocial treatments for child and adolescent depression.Combined cognitive-behavioural therapy and pharmacotherapy for adolescent depression: Does it improve outcomes compared with monotherapy?A review of co-morbid depression in pediatric ADHD: etiology, phenomenology, and treatment.Suicidal events in the Treatment for Adolescents With Depression Study (TADS).Dosing of Selective Serotonin Reuptake Inhibitors Among Children and Adults Before and After the FDA Black-Box WarningAdolescent depression: an update and guide to clinical decision making.Estimating the size of treatment effects: moving beyond p valuesPharmacotherapy of major depressive disorder in adolescents.Somatic complaints in anxious youth.Pharmacotherapy and psychotherapy of pediatric depression.Antidepressants and psychostimulants in pediatric populations: is there an association with mania?The treatment of suicidality in adolescents by psychosocial interventions for depression: A systematic literature review.Pharmacological treatment of children and adolescents with depression.Selective serotonin reuptake inhibitors and suicidality: a guide for the perplexed.Findings from the Treatment for Adolescents with Depression Study (TADS): what have we learned? What do we need to know?DEPRESSION IN ADOLESCENTS: CURRENT TREATMENTS, SUICIDALITY AND EVALUATION OF NOVEL TREATMENT STRATEGIES.Antidepressants in paediatric depression: do not look back in anger but around in awareness.Pharmacological treatment of anxiety disorders in children and adolescents: a review for practitioners.
P2860
Q24187033-19CDCE1A-A160-42BF-BFE5-26B44E916456Q24202873-82BF428A-CDAE-4B90-BA24-8A6C4DC582CAQ24607463-5212135C-0A6D-46F8-BCC2-412757F3D197Q27021267-DA1BE4E8-C643-4461-BAE4-A7970005B46CQ27024790-80280D66-D296-460A-9959-D94CD57B90A5Q33659631-C5A4D6CB-AFD2-46C1-BBA8-AA1602B105E8Q33682734-EA05B2E4-0333-411C-9820-2B16C4C6911FQ33808467-62000CD6-E9AD-468D-9A66-86806F346008Q33819922-1EFCBCB3-613B-42D8-8016-B8959779555CQ33851855-740E24FB-279D-42F9-8BC5-1BB7B2359EC7Q34019994-90D69CF1-DF19-44E1-ABB5-D71F5C65A0D4Q34253997-D10BA9B6-BFDB-4F3A-BEA0-3351870A85E2Q34266674-3E839D68-8507-41D0-A302-7927CD959CFDQ34504812-51AC983F-9EB8-4126-B0D0-8C392B2D140CQ35671518-767599EF-61CF-4D27-960F-F3F81C815CE2Q35823956-A50C397C-D45D-44BB-B785-E76ABE8AA971Q35849768-86FD0504-8334-4BFE-AC0E-6067FFEE0BC9Q35924388-93C1EDE3-5F0D-4489-8CB2-43E2934F26B8Q36514240-CA999D27-FC51-44DB-A02F-167431CE69EDQ36683244-D722A48B-6020-4C0C-AA85-6DD0F02CA704Q36804025-3BF7A210-3211-48DF-9142-BBA7502915BDQ36877283-9305598D-EE65-40ED-95B1-31A2B7D97DBAQ37150108-899FD3FD-8EA1-451A-BF70-DAA5EEFB8B56Q37165235-9D2A7603-C1AC-4628-BD92-1B81F0131D87Q37235736-10BD70D0-312C-4335-AD28-0E56030377ACQ37243110-E2CBB81C-9D7A-4A08-A66F-99CA603CE1C0Q37275848-BCD31BAF-2BE5-4CF2-860D-FC207A8522DDQ37397383-D5D6E9E5-77A0-4D93-9C51-FFA600E3D288Q37654952-D5937BA4-C2FE-44B1-BB04-29DFA5512AB7Q37681565-AE1DD102-B99A-432B-AE37-164AC148A676Q37707200-15F21AFD-454F-40E5-91C3-E9DA5ED70C4AQ37779801-70B97138-CDA0-40C0-AE06-D3B01524F9EFQ37892521-6525A32B-599A-46EC-991A-69D5218F6F68Q38741544-6B2C6714-C9D6-4091-BB89-0B6C837BDDE2Q38969019-7A547C41-36D1-4ECF-B390-8908A6AE31E4Q43485699-6982A2C4-483C-4A4B-889C-07A53D2B0820Q46970440-5720C39F-7F59-45D2-9E8C-B9A1BED7197DQ47104899-1D423465-594F-45DF-AAA6-C4F7A26A8458Q47549979-B88A6A46-8B01-4305-B667-5665023181C8Q49277998-F19F2E90-CB8C-4610-9EE0-8EBE525D24F7
P2860
Treatment for Adolescents with Depression Study (TADS): safety results
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Treatment for Adolescents with Depression Study (TADS): safety results
@ast
Treatment for Adolescents with Depression Study (TADS): safety results
@en
type
label
Treatment for Adolescents with Depression Study (TADS): safety results
@ast
Treatment for Adolescents with Depression Study (TADS): safety results
@en
prefLabel
Treatment for Adolescents with Depression Study (TADS): safety results
@ast
Treatment for Adolescents with Depression Study (TADS): safety results
@en
P2093
P2860
P1476
Treatment for Adolescents with Depression Study (TADS): safety results
@en
P2093
Benedetto Vitiello
Bruce Waslick
Charles Casat
Christopher Kratochvil
Columbia Suicidality Classification Group
Elizabeth Weller
Graham Emslie
John March
John Walkup
Kelly Posner
P2860
P304
P356
10.1097/01.CHI.0000240840.63737.1D
P577
2006-12-01T00:00:00Z